Rishi G Vaswani

This inventor holds 28 USPTO granted patents and 11 published patent applications, plus 3 CIPO patents and 11 EPO patents, primarily in Epigenetic Modulation. Top assignees: Constellation Pharmaceuticals, Inc., Foghorn Therapeutics Inc., Genentech, Inc.. Active years: 2014-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Rishi G Vaswani. Retrieved from https://idiyas.com/inventor/rishi-g-vaswani

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 28 (Patent Applications = 11)

% Patents Active = 100.0

CIPO Patents = 3 (Patent Applications = 8)

EPO Patents = 11 (Patent Applications = 22)

Average Co-Inventor Count = 4.8

ph-index = 8

Forward Citations = 147(Granted Patents)

Location History:

Newton, MA (US) (2014 - 2017)
Cambridge, MA (US) (2019)
Lexington, MA (US) (2016 - 2022)

Company Filing History:

17 out of 56

Constellation Pharmaceuticals, Inc.

patents

10 out of 26

Foghorn Therapeutics Inc.

Recludix Pharma, Inc.

patent

where one patent can have more than one assignee

Years Active: 2014-2026

Loading Chart...

Areas of Expertise:

BRM/BRG1 Inhibitors

STAT6 Modulators

BAF Complex Modulating Compounds

Methyl Modifying Enzymes

LSD1 Inhibitors

EZH2 Inhibitors

Crystalline Forms

Indole Derivatives

Benzo Isoxazoloazepine

Bromodomain Inhibitors

Therapeutic Compounds

Compositions

28 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12741966 - BRM/BRG1 inhibitors and uses thereof (2026-09-22),

2. 12709628 - STAT6 MODULATORS AND USES THEREOF (2026-08-18),

3. 12685735 - BAF complex modulating compounds (2026-07-21),

4. 12649737 - Compounds and uses thereof (2026-06-09),

5. 12606553 - Crystalline forms, compositions containing same, and methods of their use (2026-04-21),

6. 12509453 - BRM/BRG1 inhibitors and uses thereof (2025-12-30),

7. 12486262 - Compounds and uses thereof (2025-12-02),

8. 12384776 - Compounds and uses thereof (2025-08-12),

9. 12383560 - Compounds and uses thereof (2025-08-12),

10. 11497752 - Compounds and uses thereof (2022-11-15),

11. 11485732 - Compounds and uses thereof (2022-11-01),

12. 10526287 - LSD1 inhibitors and uses thereof (2020-01-07),

13. 10457640 - Synthesis of inhibitors of EZH2 (2019-10-29),

14. RE47428 - Modulators of methyl modifying enzymes, compositions and uses thereof (2019-06-10),

15. 10301253 - Therapeutic compounds and uses thereof (2019-05-28),

Title: Inventor Spotlight: Rishi G Vaswani

Introduction:

Rishi G Vaswani is a prolific inventor based in Lexington, Massachusetts, with an impressive portfolio of 19 patents to his name. His innovative work in developing compounds for the treatment of BAF complex-related disorders has positioned him as a trailblazer in the field of pharmaceutical research.

Latest Patents:

Among his latest patents are "Compounds and uses thereof" which showcase his dedication to finding novel solutions for the treatment of BAF complex-related disorders. These compounds hold significant promise in addressing crucial medical needs and improving patient outcomes.

Career Highlights:

Rishi G Vaswani has made significant contributions to the pharmaceutical industry through his work with renowned companies such as Constellation Pharmaceuticals, Inc. and Foghorn Therapeutics Inc. His expertise and dedication have been instrumental in advancing cutting-edge research and developing groundbreaking therapies.

Collaborations:

Throughout his career, Rishi G Vaswani has collaborated with esteemed professionals in the field, including Brian K Albrecht and Victor S Gehling. These collaborations have enriched his work, fostered innovation, and led to the creation of impactful solutions for complex medical conditions.

Conclusion:

Inventor Rishi G Vaswani's exceptional work and dedication to advancing pharmaceutical research have cemented his reputation as a visionary in the field. His innovative patents and collaborations stand as a testament to his commitment to improving healthcare and transforming the landscape of drug discovery.

Profile summary based on public USPTO records.